SMTL ID : 7a1o.1

FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH ZN(II), 4-ethyl-2-oxoglutarate, AND CONSENSUS ANKYRIN REPEAT DOMAIN (20-MER)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

hetero-2-2-mer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: H.199, D.201, H.279, W.296 Chain B: N.16 Ligands: QVT.5 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.199, A:D.201, A:H.279 ZN.7: 6 residues within 4Å: Chain C: H.199, D.201, H.279, W.296 Chain D: N.16 Ligands: QVT.11 3 PLIP interactions: 3 interactions with chain C Metal complexes: C:H.199, C:D.201, C:H.279

8 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: D.222, K.311, A.312 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:D.222, A:D.222, A:A.312 Water bridges: A:H.313 SO4.3: 5 residues within 4Å: Chain A: R.143, E.192, G.193, L.285, N.286 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.192, A:N.286 Salt bridges: A:R.143 SO4.4: 2 residues within 4Å: Chain A: R.44, T.65 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.65, A:T.65 Salt bridges: A:R.44 SO4.6: 4 residues within 4Å: Chain A: R.138, G.140, E.141, E.142 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.141, A:E.142, A:E.142 Salt bridges: A:R.138 SO4.8: 3 residues within 4Å: Chain C: D.222, K.311, A.312 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:D.222, C:A.312 Water bridges: C:H.313 SO4.9: 5 residues within 4Å: Chain C: R.143, E.192, G.193, L.285, N.286 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:E.192, C:N.286 Salt bridges: C:R.143 SO4.10: 2 residues within 4Å: Chain C: R.44, T.65 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:T.65, C:T.65 Salt bridges: C:R.44 SO4.12: 4 residues within 4Å: Chain C: R.138, G.140, E.141, E.142 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:E.141, C:E.142 Salt bridges: C:R.138

2 x QVT: 4-ethyl-2-oxoglutarate(Non-covalent)

QVT.5: 16 residues within 4Å: Chain A: Y.145, Q.147, L.186, L.188, T.196, H.199, D.201, N.205, F.207, K.214, H.279, I.281, N.294, W.296 Chain B: N.16 Ligands: ZN.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.186, A:L.188, A:L.188, A:F.207 Hydrogen bonds: A:Y.145, A:N.205, A:N.294, A:W.296 Salt bridges: A:K.214, A:H.279 QVT.11: 16 residues within 4Å: Chain C: Y.145, Q.147, L.186, L.188, T.196, H.199, D.201, N.205, F.207, K.214, H.279, I.281, N.294, W.296 Chain D: N.16 Ligands: ZN.7 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:L.186, C:L.188, C:L.188, C:F.207 Hydrogen bonds: C:Y.145, C:N.205, C:N.294, C:W.296 Salt bridges: C:K.214, C:H.279

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nakashima, Y. et al., 2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases. Nat Commun (2021)

Release Date

2021-08-25

Peptides

Hypoxia-inducible factor 1-alpha inhibitor: AC
CONSENSUS ANKYRIN REPEAT DOMAIN: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
A

B
B

D
B

Hypoxia-inducible factor 1-alpha inhibitor

CONSENSUS ANKYRIN REPEAT DOMAIN

Related Entries With Identical Sequence